Study optimizing chemo-enzymatic synthesis of (3aS, 6aR)-lactone in E. coli, implying an efficient industrial method.
The (3aS, 6aR)-lactone serves as the key chiral intermediate for the synthesis of d-biotin. A promising approach involves the asymmetric hydrolysis of meso-dimethyl ester catalyzed by an esterase to yield the (4S, 5R)-monomethyl ester, which is subsequently reduced and cyclized to afford (3aS, 6aR)-lactone. This study first optimized the fermentation medium and culture conditions for the recombinant E. coli pET21a-EstSIT01 harboring the Microbacterium esterase gene, which exhibits high selectivity for the asymmetric synthesis of (4S, 5R)-monomethyl ester. Under optimal conditions (fermentation medium: glycerol 25 g/L, yeast extract 15 g/L, NaCl 10 g/L, MgSO4•7H2O 5 g/L; induction was initiated 2 h post-inoculation at 30 °C and pH 7.2), the enzyme activity increased 5.1-fold compared to the initial level, reaching 1072.7 U/L. Secondly, the reaction conditions for the whole-cell synthesis of (4S, 5R)-monomethyl ester catalyzed by EstSIT01 were optimized. The results indicated that organic solvents adversely affected enzyme stability, while high buffer salt concentration negatively impacted enzyme activity at elevated substrate concentrations. The optimal reaction strategy involved maintaining the pH of the aqueous reaction system at 7.5 by the controlled addition of aqueous ammonia to neutralize the (4S, 5R)-monomethyl ester produced during the reaction. Using 17.5 g/L cells and 200 mM substrate meso-dimethyl ester in deionized water, with the reaction pH mentioned at 7.5, complete conversion (100%) was achieved within 4 h at 30 °C. The space–time yield reached 441.6 g/L/d, exceeding the typical requirement for industrial biotransformation (>100 g/L/d), with 99.1% enantiomeric excess (ee) of (4S, 5R)-monomethyl ester. Finally, (4S, 5R)-monomethyl ester was reduced using sodium borohydride to synthesize (3aS, 6aR)-lactone with an ee value of 98.7%. The overall yield from meso-dimethyl ester to (3aS, 6aR)-lactone was 86.2%. These results demonstrate that this integrated chemo-enzymatic approach constitutes a greener method with promising potential for industrial application.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: